Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

52.2K
Overview
52.2K
Development of Immunocompetence01:22

Development of Immunocompetence

1.0K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.6K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.6K
Preventive Healthcare Services01:30

Preventive Healthcare Services

2.2K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.2K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

4.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.4K
Prevalence and Incidence01:08

Prevalence and Incidence

2.0K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-Term Safety and Adverse Event Risk Profiles for SARS-CoV-2 Booster Vaccine Doses in Australian Adults: A Survey Study.

The Medical journal of Australia·2026
Same author

Vaccine uptake in the context of mandate announcement and removal: Evidence from Europe and North America.

Vaccine·2026
Same author

Mpox disease epidemiology, vaccine uptake and vaccination coverage in Australia 2022-2024: a descriptive study.

EClinicalMedicine·2026
Same author

Annual immunisation coverage report 2024.

Communicable diseases intelligence (2018)·2026
Same author

ATAGI 2024 Annual Statement on Immunisation.

Communicable diseases intelligence (2018)·2026
Same author

ATAGI 2025 Annual Statement on Immunisation.

Communicable diseases intelligence (2018)·2026
Same journal

Measles epidemiology in Australia: 2014 to 2024. Erratum to 10.33321/cdi.2026.50.016.

Communicable diseases intelligence (2018)·2026
Same journal

Presymptomatic transmission, vaccine breakthrough and anonymous contacts: a cluster of mpox in Canberra, Australian Capital Territory, 2024.

Communicable diseases intelligence (2018)·2026
Same journal

The Strategic Plan for Tuberculosis Elimination and Equity in Australia 2026-2030.

Communicable diseases intelligence (2018)·2026
Same journal

An atlas of common Salmonella serotypes from routinely notified human cases in the Northern Territory of Australia, 2005-2024.

Communicable diseases intelligence (2018)·2026
Same journal

Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026
Same journal

Australian Gonococcal Surveillance Program, 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026
See all related articles

Related Experiment Video

Updated: Feb 25, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K

Annual Immunisation Coverage Report 2023.

Brynley Hull1, Alexandra Hendry2, Kristine Macartney2

  • 1National Centre for Immunisation Research and Surveillance, The Children's Hospital at Westmead and The University of Sydney. brynley.hull@health.nsw.gov.au.

Communicable Diseases Intelligence (2018)
|February 23, 2026
PubMed
Summary
This summary is machine-generated.

Australian vaccination coverage for children and adolescents declined in 2023, with lower rates observed in Indigenous populations. Adult vaccination rates show mixed trends, with some vaccines increasing but overall coverage remaining suboptimal, highlighting ongoing access and acceptance issues.

Keywords:
Aboriginal and Torres Strait Islander vaccination coverageinfluenza vaccinationvaccination coveragevaccination timeliness

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K
Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test
07:54

Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test

Published on: January 19, 2024

3.4K

Related Experiment Videos

Last Updated: Feb 25, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K
Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test
07:54

Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test

Published on: January 19, 2024

3.4K

Area of Science:

  • Public Health and Epidemiology
  • Immunisation and Vaccine Preventable Diseases
  • Health Services Research

Background:

  • Analysis of Australian Immunisation Register (AIR) data for National Immunisation Program (NIP) funded vaccines.
  • Focus on calendar year 2023, with trends from previous years for children, adolescents, and adults.
  • Data as at 4 February 2024.

Purpose of the Study:

  • To provide comprehensive analysis and interpretation of vaccination coverage data.
  • To inform immunisation policy and programs.
  • To identify trends and factors affecting vaccination uptake.

Main Methods:

  • Analysis of Australian Immunisation Register (AIR) data.
  • Focus on vaccination coverage at key age milestones for children and adolescents.
  • Examination of adult vaccination coverage for specific vaccines (zoster, pneumococcal, influenza).

Main Results:

  • Childhood vaccination coverage decreased in 2023 compared to 2022 across multiple age milestones, with greater declines in Indigenous children.
  • Adolescent vaccination coverage for HPV and meningococcal ACWY vaccines declined, particularly impacting Indigenous adolescents and those in socio-economically disadvantaged areas.
  • Adult vaccination coverage showed mixed results: zoster coverage stable, 13-valent pneumococcal conjugate vaccine (13vPCV) increased, and influenza coverage decreased across all age groups.

Conclusions:

  • Modest but concerning declines in vaccination coverage persist for children and adolescents, with higher decreases in Indigenous populations.
  • Adult vaccination coverage is mixed but consistently suboptimal, with influenza vaccination showing widespread decreases.
  • Complex factors, including vaccine acceptance and access issues, contribute to declining and suboptimal coverage, necessitating ongoing monitoring and targeted interventions.